Abstract
Marihuana has been shown to decrease host resistance to bacterial, protozoan, and viral infections in experimental animal models and in vitro systems. Recent immuno epidemiological studies suggest that marihuana may also influence the outcome of viral infections in humans. The main substance in marihuana that exerts these immuno depressive effects is its major psychoactive constituent Δ9-tetrahydrocannabinol (THC). This cannabinoid alters the function of an array of immune cells including lymphocytes, natural killer cells, and macrophages, thereby affecting their capacity to exert anti microbial activities. Two modes of action by which THC affects immune responsiveness have been proposed. At sites such as the lung that are subject to exposure to high concentrations of THC and other cannabinoids contained in marihuana smoke, THC may alter cellular membranes because of its highly lipophilic nature. In contrast, at sites distal to the lung, THC at relatively low concentrations may exert its suppressive effects on immune cells by interacting with cannabinoid receptors CB1 and CB2. No controlled longitudinal epidemiological studies have yet correlated the immunosuppressive effects of Cannabis smoke on the incidence of infections or viral disease in different segments of the population.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Dewey, W. L. (1986) Cannabinoid pharmacology. Parmcol. Rev. 38, 151–178.
Nahas, G. G., Suciu-Foca, N., Armand, J. P., and Morishima, A. (1974) Inhibition of cellular mediated immunity in marihuana smokers. Science 183, 419–420.
Cushman, P. and Khurana, R. (1976) Marihuana and T lymphocyte rosettes. Clin. Pharmacol. Ther. 19, 310–317.
Klein, T. W., Newton, C., Widen, R., and Friedman, H. (1985) The effect of delta-9-tetrahydrocannabinol and 11-hydroxy-delta-9-tetrahydrocannabinol on T-lymphocyte and B-lymphocyte mitogen responses. J. Immunopharmacol. 7, 451–466.
Munson, A. E., Levy, J. A., Harris, L. S., and Dewey, W. L. (1976) Effects of delta-9-tetrahydrocannabinol on the immune system, in The Pharmacology of Marijuana ( Braude, M. C., and Szara, S., eds.) Raven, New York, pp. 187–197.
Baczynsky, W. O. T. and Zimmerman, A. M. (1983) Enhanced growth of Legionella pneumophila tetrahydrocannabinol-treated macrophages. Proc. Soc. Exp. Biol. Med. 199 (1), 65–67.
Klein, T. W., Newton, C., and Friedman, H. (1987) Inhibition of natural killer cell function by marijuana components. J. Toxicol. Environ. Health 20, 321–332.
Lopez-Cepero, M., Friedman, M., Klein, T., and Friedman, H. (1986) Tetrahydrocannabinol-induced suppression of macrophage spreading and phagocyte activity in vitro. J. leuk. Biol. 39, 679–686.
Cabral, G. A. and Vasquez, R. (1991) Marijuana decrease macrophage antiviral and antitumor activities. Adv. Biosci. 80, 93–105.
Burnette-Curley, d., Marciano-Cabral, F., Fischer-Stenger, K., and Cabral, G. A. (1993) 0–9-tetrahydrocannabinol inhibits cell contact-dependent cytotoxicity of bacillus Calmétte-Guérin-activated macrophages. Int. J. Immunopharmacol. 15, 371–382.
Gross, G., Roussaki, A., Ikenberg, H., and Dress, N. (1991) Genital warts do not respond to systemic recombinant interferon alpha-2a treatment during cannabis consumption. Dermatol. 183, 203–207.
Tindall, B., Cooper, D. A., Donovan, B., Barnes, T., Philpot, C. R., Gold, J., and Penny, R. (1988) The Sydney AIDS Project: development of acquired immnodeficiency syndrome in a group of HIV seropositive homosexual men. Aust. N.Z. J. Med. 18 (1), 8–15.
Morahan, P. S., Klykken, P. C., Smith, S. H., Harris, L. S., and Munson, A. E. (1979) Effects of cannabinoids on host resistance to Listeria monocytogenes and herpes simplex virus. Infect. Immun. 23, 670–674.
Mishkin, E. M. and Cabral, G. A. (1985) Delta-9-tetrahydrocannabinol decreases host resistance to herpes simplex virus type 2 vaginal infection in B6C3F1 mice. J. Gen. Virol. 66, 2539–2549.
Cabral, G. A., Mishkin, E. M., Marciano-Cabral, F., Coleman, P., Harris, L., and Munson, A. E. (1986) Effect of delta-9-tetrahydrocannabinol on herpes simplex virus type 2 vaginal infection in the guinea pig. Proc. Soc. Exp. Biol. 182, 181–186.
Klykken, P. C., Smith, S. H., Ley, J. A., Razdan, R., and Munson, A. E. (1977) Immuno suppressive effects of 8.9-eposyhexandrocannabinol (EHHC). J. Pharmacol. Exp. Ter. 201, 573–579.
Smith, S. H., Harris, L. S., Uwaydah, L. M., and Munson, A. E. (1978) Structure-activity relationships of natural and synthetic cannabinoids in suppression of humoral and cell-mediated immunity. J. Pharmacol. Exp. Ther. 207, 165–170.
Specter, S. C., Lancz, G., Westrich, G., and Friedman, H. (1991) Delta-9-tetrahydrocannabinol augments murine retroviral induced immunosuppression and infection. Int. J. Immunopharmacology 13 (4), 411–417.
Klein, T. W., Newton, C., Widen, R., and Friedman, H. (1993) Delta-9-tetrahydrocannabinol injection induces cytokine-mediated mortality of mice infected with Legionella pneumophila. J. Pharmacol. Exp. Ther. 267 (2), 635–640.
Rosenkrantz H. (1976) The immune response and marihuana, in Marihuana: Chemistry, Biochemistry & Cellular Effects. (Nahas G. G., Paton W. D. M., and Idanpaan-Heikkila J., eds.) Springer-Verlag, New York, p. 441.
Hembree, W. C., Nahas G., Zeidenberg, P. and Huang, H. F. S. (1979) Changes in human spermatozoa associated with high dose marihuana smoking, in Marihuana: Biological Effects, Analysis, Cellular Responses, Reproduction and Brain. ( Nahas G. G. and Paton W. D. M., eds.) Pergamon, New York, pp. 429–439.
Stevens, J. G. and Cook, M. L. (1971) Restriction of herpes simplex virus by macrophages. N analysis of the cell-virus integration. J. Exp. Med. 133, 19–38.
Selgrade, M. K. and Osborne, J. E. (1974) Role of macrophages in resistance to murine cytomegalovirus. Infect. Immun. 10, 1381–1390.
Morahan, P. S., Glasgow, L. A., Crane, J. L., Jr., and Kern, E. R. (1977) Comparison of antiviral and antitumor activity of activated macrophages. Cell Immunol. 28, 404–415.
Cabral, G. A. and Vasquez, R. (1992) Delta-9-tetrahydrocannabinol suppresses macrophage extrinsic antiherpesvirus activity, in Cannabis: Physiopathology, Epidemiology, Detection ( Nahas, G. G. and Latour, C., eds.) CRC Press, Boca Raton, FL, pp. 137–153.
Arata, S., Klein, T. W., Newton, C., and Friedman, H. (1991) Tetrahydrocannabinol treatment suppresses growth restriction of Legionella pneumophila in murine macrophage cultures. Life Sci. 49, 473–479.
Marciano-Cabral, F. (1988) Biology of Naegleria spp. Microbiol. Revs. 52, 114–133.
Wing, D. R., Leuschner, J. T. A., Brent, G. A., Harvey, D. J., and Paton, W. D. M. (1985) Quantification of in vivo membrane associated delta-9-tetrahydrocannabinol and its effects on membrane fluidity, in Proceedings of the 9th International Congress of Pharmacology 3rd Satellite Symposium on Cannabis ( Harvey, D. J., ed.) IRL Press, Oxford, UK pp. 411–418.
Carrasco, L. and Smith, A. E. (1976) Sodium ions and the shut-off of host cell protein synthesis by piconviruses. Nature (London) 264, 807–809.
Garry, R. F., Bishop, J. M., Parker, S., Westbrook, K, Lewis, G., and Waite, M. R. E. (1979) Na+ and K+ concentrations and the regulation of protein synthesis in sindbis virus-infected chick cells. Virology 96, 108–120.
Desoize, B., Leger C., and Nahas, G. G. (1979) Plasma membrane inhibition of macromolecular precursor transport by THC. Biochemical Pharmacology, 28, 1113–1118.
Poddar, M. K., Mitra, G., and Ghosh, J. J. (1978) Delta-9-tetrahydrocannabinol-induced changes in brain ribosomes. Toxicol. Appl. Pharmacol. 46, 737–757.
Nahas, G. G., Morishima, A., and Desoize, B. (1977) Effects of cannabinoids on macromolecular synthesis and replication of cultured lymphocytes. Fed. Proc. 36, 1748–1752.
Matsuda, L. A., Lolait, S. J1, Brownstein, M. J., Young, A. C., and Bonner, T. I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561–556.
Chakrabarti, A., Onaivi, E. S., and Chaudhuri, G. (1995) cloning and sequencing of a cDNA encoding the mouse brain-type cannabinoid receptor protein. DNA Seq.-J. Seq. Map 5, 385–388.
Gérard, C., Mollereau, C., Vassart, G., and Parmentier, M. (1990) Nucleotide sequence of a human cannabinoid receptor cDNA. Nucleic Acids Res. 18, 7142.
Howlett, A. C., Qualy, J. M., and Khachchatrian, L. L. (1986) Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol. Pharmacol. 29, 307–313.
Mackie, K. and Hille, B. (1992) Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. USA 89, 3825–3829.
Selley, D. E., Stark, S., and Childers, S. R. (1996) Cannabinoid receptor stimulation of [35S]GTPy S binding in rat brain membranes. Life Sci. 59, 659–668.
Childers, S. R. and Deadwyler, S. A. (1996) Role of cyclic AMP in the actions of cannabinoid receptors. Biochem. Pharmacol. 52, 819–827.
Kaminski, N. E., Abood, M. E., Kessler, E K., Martin, B. R., and Schatz, A. R. (1992) Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation. Mol. Pharmacol. 42, 736–742.
Bouaboula, M., Rinaldi, M., Carayon, P., Carillon, C., Delpech, B., Shire, D. Le Fur, G., and Casellas, P. (1993) Cannabinoid-receptor expression in human leukocytes. Eur. J. Biochem. 214, 173–180.
Munro, S., Thomas, K. L., and Abu-Shaar, M. (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61–65.
Galiègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D., Le Fur, G., and Casellas, P. (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 232, 54–61.
Lynn, A. B. and Herkenham, M (1994) Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids. J. Pharmacol. Exp. Ther. 268, 1612–1623.
Dove-Pettit, D. A., Anders, D. L., Harrison, M. P., and Cabral, G. A. (1996) Cannabinoid receptor expression in immune cells. Adv. Exp. Med. Biol. 402, 119–129.
Kaminski, N. E., Koh, W. S., Yang, K. H., Lee, M., and Kessler, F. K. (1994) Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism. Biochem. Pharmacol. 48, 1899–1908.
McCoy, K. L., Gainey, D., and Cabral, G. A. (1995) 49-Tetrahydrocannabinol modulates antigen processing by macrophages. J. Pharmacol. Exp. Ther. 273, 1216–1223.
Clements, D., Cabral, G. A., and McCoy, K. L. (1996) Delta-9-tetrahydrocannabinol selctively inhibits macrophage co-stimulatory activity and down-regulates heat-stable antigen expression. J. Pharmacol. Exp. Ther. 277, 1315–1321.
Felder, C. C., Joyce, K. E., Briley, E. M., Mansouri, J., Mackie, K., Blond, O., Lai, Y., Ma, A. L., and Mitchell, R. L. (1995) Comparison of the pharmacology and signal transduction of the human cannabinoid CBI and CB2 receptors. Mol. Parmcol. 48, 443–450.
Watzl, B., Scuderi, P., and Watson, R. R. (1991) Marijuana components stimulate human peripheral blood mononuclear cell secretion of interferon-gamma and suppress interleukin-1-alpha in vitro. Int. J. Immunopharmacol. 13, 1091–1097.
Nakano, Y., Pross, S. H., and Friedman, H. (1992) Modulation of interleukin 2 activity by delta-9-tetrahydrocannabinol and stimulation with concanavalin A, phytohemagglutinin, or anti-CD3 antibody. Proc. Soc. Exp. Biol. Med. 20, 165–168.
Zheng, Z. M., Specter, S., and Friedman, H. (1992) Inhibition by delta-9-tetrahydrocannabinol of tumor necrosis factor alpha production by mouse and human macrophages. Int. J. Immunopharmacology 14, 1445–1452.
Fisher-Stenger, K., Dove Pettit, D. A., and Cabral, G. A. (1993) A9Tetrahydrocannabinol inhibition of tumor necrosis factor-alpha: suppression of post-translational events. J. Pharmacol. Exp. Ther. 267, 1558–1565.
Houston, D. B. and Howlett, A. C. (1993) Solubilization of the cannabinoid receptor from rat brain and its functional interaction with guanine nucleotide-binding proteins. Mol. Pharmacol. 43, 17–22.
Howlett, A. C., Champion, T. M., Wilken, G. H., and Mechoulam, R. (1990) Stereochemical effects of 11OH-8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor. Neuropharmacology 29, 161–165.
Facci, L., Dal Toso, R., Romanello, S., Buriani, A., Skaper, S. D., and Leon, A. (1995) Mast cells express a peripheral receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc. Natl. Acad. Sci. USA 92, 3376–3380.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Cabral, G.A. (1999). Marihuana and the Immune System. In: Nahas, G.G., Sutin, K.M., Harvey, D., Agurell, S., Pace, N., Cancro, R. (eds) Marihuana and Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-710-9_32
Download citation
DOI: https://doi.org/10.1007/978-1-59259-710-9_32
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-5717-0
Online ISBN: 978-1-59259-710-9
eBook Packages: Springer Book Archive